Galectin Therapeutics Announces Conversion of $105.8 Million in Debt to Equity, Significantly Strengthening Balance Sheet

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. IONQ
2. IONS
3. SPY
4. ORCL
5. CRCL
6. V
7. GE
8. ASML
9. SPIR
10. NVDA

Go back to Galectin Therapeutics Announces Conversion of $105.8 Million in Debt to Equity, Significantly Strengthening Balance Sheet
GALECTIN (NASDAQ: GALT) Delayed: 4.61 --0 (-0%)
Previous Close $4.61    52 Week High $3.05 
Open $4.61    52 Week Low $0.49 
Day High $4.61    P/E N/A 
Day Low $4.61    EPS $-1.32 
Volume 1,694